Correlation Between Intermedical Care and Mega Lifesciences
Can any of the company-specific risk be diversified away by investing in both Intermedical Care and Mega Lifesciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Intermedical Care and Mega Lifesciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Intermedical Care and and Mega Lifesciences Public, you can compare the effects of market volatilities on Intermedical Care and Mega Lifesciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Intermedical Care with a short position of Mega Lifesciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Intermedical Care and Mega Lifesciences.
Diversification Opportunities for Intermedical Care and Mega Lifesciences
0.48 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Intermedical and Mega is 0.48. Overlapping area represents the amount of risk that can be diversified away by holding Intermedical Care and and Mega Lifesciences Public in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mega Lifesciences Public and Intermedical Care is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Intermedical Care and are associated (or correlated) with Mega Lifesciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mega Lifesciences Public has no effect on the direction of Intermedical Care i.e., Intermedical Care and Mega Lifesciences go up and down completely randomly.
Pair Corralation between Intermedical Care and Mega Lifesciences
Assuming the 90 days trading horizon Intermedical Care and is expected to under-perform the Mega Lifesciences. But the stock apears to be less risky and, when comparing its historical volatility, Intermedical Care and is 2.24 times less risky than Mega Lifesciences. The stock trades about -0.24 of its potential returns per unit of risk. The Mega Lifesciences Public is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest 3,250 in Mega Lifesciences Public on December 25, 2024 and sell it today you would lose (75.00) from holding Mega Lifesciences Public or give up 2.31% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Intermedical Care and vs. Mega Lifesciences Public
Performance |
Timeline |
Intermedical Care |
Mega Lifesciences Public |
Intermedical Care and Mega Lifesciences Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Intermedical Care and Mega Lifesciences
The main advantage of trading using opposite Intermedical Care and Mega Lifesciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Intermedical Care position performs unexpectedly, Mega Lifesciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mega Lifesciences will offset losses from the drop in Mega Lifesciences' long position.Intermedical Care vs. Inter Pharma Public | Intermedical Care vs. Ekachai Medical Care | Intermedical Care vs. Humanica Public | Intermedical Care vs. Bangkok Chain Hospital |
Mega Lifesciences vs. Home Product Center | Mega Lifesciences vs. Minor International Public | Mega Lifesciences vs. Com7 PCL | Mega Lifesciences vs. Bangkok Dusit Medical |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Other Complementary Tools
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories |